8924 related articles for article (PubMed ID: 10338332)
41. 5-Fluorouracil increases susceptibility of renal cell cancer cell lines to lymphokine-activated killer cells: evidence for alteration not at the level of recognition but at a post-binding stage of the lytic cycle.
Tomita Y; Imai T; Katagiri A; Kimura M; Saitoh K; Sato S
Cancer Lett; 1993 Nov; 75(1):27-34. PubMed ID: 7904537
[TBL] [Abstract][Full Text] [Related]
42. Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing.
Wiebke EA; Custer MC; Rosenberg SA; Lotze MT
J Biol Response Mod; 1990 Apr; 9(2):113-26. PubMed ID: 2111373
[TBL] [Abstract][Full Text] [Related]
43. ICAM-1 increases in vitro adhesion and cytotoxicity in a murine fibrosarcoma.
Burno DK; Fabian DF; Lefor AT
J Surg Res; 1996 Feb; 60(2):398-402. PubMed ID: 8598676
[TBL] [Abstract][Full Text] [Related]
44. Membrane-associated lymphotoxin-expressing lymphokine-activated killer cells up-regulate intercellular adhesion molecule-1 expression on target tumor cells in vitro.
Kimura K; Abe Y; Horiuchi A; Miyake M; Kimura S
Cell Immunol; 1995 Aug; 164(1):119-25. PubMed ID: 7634343
[TBL] [Abstract][Full Text] [Related]
45. Lysis of allogeneic and autologous melanoma cells by IL-7-induced lymphokine-activated killer cells.
Böhm M; Möller P; Kalbfleisch U; Worm M; Czarnetzki BM; Schadendorf D
Br J Cancer; 1994 Jul; 70(1):54-9. PubMed ID: 8018541
[TBL] [Abstract][Full Text] [Related]
46. Enhancement of lymphokine-activated killer cell cytotoxicity implicated in the increased expression of surface adhesion molecules on tumor cells treated with anticancer agents.
Ishihata R; Ejiri Y; Okubo M; Ohara M; Kasukawa R
Cancer Invest; 1996; 14(5):427-34. PubMed ID: 8816858
[TBL] [Abstract][Full Text] [Related]
47. Effect of human interleukin 3 on the susceptibility of fresh leukemia cells to interleukin-2-induced lymphokine activated killing activity.
Cesano A; Lista P; Bellone G; Geuna M; Brizzi MF; Rossi PR; Pegoraro L; Oberholtzer E; Matera L
Leukemia; 1992 Jun; 6(6):567-73. PubMed ID: 1376379
[TBL] [Abstract][Full Text] [Related]
48. Two new human cholangiocarcinoma cell lines and their cytogenetics and responses to growth factors, hormones, cytokines or immunologic effector cells.
Shimizu Y; Demetris AJ; Gollin SM; Storto PD; Bedford HM; Altarac S; Iwatsuki S; Herberman RB; Whiteside TL
Int J Cancer; 1992 Sep; 52(2):252-60. PubMed ID: 1355757
[TBL] [Abstract][Full Text] [Related]
49. Interferon gamma but not tumor necrosis factor alpha decreases susceptibility of human renal cell cancer cell lines to lymphokine-activated killer cells.
Tomita Y; Watanabe H; Kobayashi H; Nishiyama T; Tsuji S; Fujiwara M; Sato S
Cancer Immunol Immunother; 1992; 35(6):381-7. PubMed ID: 1356627
[TBL] [Abstract][Full Text] [Related]
50. Resistance of chronic lymphocytic leukaemia cells to interferon-alpha generated lymphokine activated killer cells.
Jewell AP; Worman CP; Giles FJ; Goldstone AH; Lydyard PM
Leuk Lymphoma; 1992 Aug; 7(5-6):473-80. PubMed ID: 1362916
[TBL] [Abstract][Full Text] [Related]
51. Relation of natural killer cell line NK-92-mediated cytolysis (NK-92-lysis) with the surface markers of major histocompatibility complex class I antigens, adhesion molecules, and Fas of target cells.
Komatsu F; Kajiwara M
Oncol Res; 1998; 10(10):483-9. PubMed ID: 10338151
[TBL] [Abstract][Full Text] [Related]
52. Pentoxifylline inhibits integrin-mediated adherence of 12(S)-HETE and TNFalpha-activated B16F10 cells to fibronectin and endothelial cells.
Jain M; Ratheesh A; Gude RP
Chemotherapy; 2010; 56(1):82-8. PubMed ID: 20299795
[TBL] [Abstract][Full Text] [Related]
53. Differentiation-related expression of adhesion molecules and receptors on human neuroblastoma tissues, cell lines and variants.
Gross N; Favre S; Beck D; Meyer M
Int J Cancer; 1992 Aug; 52(1):85-91. PubMed ID: 1354203
[TBL] [Abstract][Full Text] [Related]
54. The high lysability by LAK cells of colon-carcinoma cells resistant to doxorubicin is associated with a high expression of ICAM-1, LFA-3, NCA and a less-differentiated phenotype.
Rivoltini L; Cattoretti G; Arienti F; Mastroianni A; Melani C; Colombo MP; Parmiani G
Int J Cancer; 1991 Mar; 47(5):746-54. PubMed ID: 1706327
[TBL] [Abstract][Full Text] [Related]
55. [LAK sensitivity of human pancreas carcinoma cell lines].
Sugiura H
Hokkaido Igaku Zasshi; 1993 Nov; 68(6):921-34. PubMed ID: 7906667
[TBL] [Abstract][Full Text] [Related]
56. Characteristics and mechanism of IFN-gamma-induced protection of human tumor cells from lysis by lymphokine-activated killer cells.
de Fries RU; Golub SH
J Immunol; 1988 May; 140(10):3686-93. PubMed ID: 3129500
[TBL] [Abstract][Full Text] [Related]
57. Role of CD18 in lymphokine activated killer (LAK) cell-mediated lysis of human monocytes: comparison with other LAK targets.
Blanchard DK; Hall RE; Djeu JY
Int J Cancer; 1990 Feb; 45(2):312-9. PubMed ID: 1968054
[TBL] [Abstract][Full Text] [Related]
58. The specificity of lymphokine-activated killer (LAK) cells in vitro: fresh normal murine tissues are resistant to LAK-mediated lysis.
Lefor AT; Rosenberg SA
J Surg Res; 1991 Jan; 50(1):15-23. PubMed ID: 1987427
[TBL] [Abstract][Full Text] [Related]
59. Adhesion molecule-mediated signals regulate major histocompatibility complex-unrestricted and CD3/T cell receptor-triggered cytotoxicity.
Galandrini R; Albi N; Zarcone D; Grossi CE; Velardi A
Eur J Immunol; 1992 Aug; 22(8):2047-53. PubMed ID: 1379184
[TBL] [Abstract][Full Text] [Related]
60. Involvement of MHC class I molecule and ICAM-1 in the enhancement of adhesion and cytotoxic susceptibility to immune effector cells of tumor cells transfected with the interleukin (IL)-2, IL-4 or IL-6 gene.
Cao X; Chen G; He L; Zhang W; Yu Y; Wang J
J Cancer Res Clin Oncol; 1997; 123(11-12):602-8. PubMed ID: 9620217
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
